Molekule Group, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2023.

Latest financial report
14 Aug 2023
Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palm Beach Gardens, FL
SEC filing record 1 source field available
Fiscal year end
31 December

Shareable Research Card

Molekule Group, Inc. Financial Facts

Molekule Group, Inc. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q2 2023
Latest reported value
Operating Margin -147%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Return Loop

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q2 2023
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q2 2023.
  • Most recent SEC facts end date on this page: 09 Aug 2023.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Create account to save this filer Open latest 10-Q/10-K hub

Latest update

Latest update for Molekule Group, Inc.

New fact period available

Latest financial period: Q2 2023. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

14 Aug 2023

Page type

Company facts

Latest period

Q2 2023

SEC-backed company facts were refreshed from filings filed on 14 Aug 2023.

Open recent updates hub Open latest 10-Q/10-K hub

Benchmark Context

How Operating Margin compares

Operating Margin is down about 98% versus the comparable prior period.

Compared with

Compared with Molekule Group, Inc.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.

Why this is notable

Operating Margin already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.

  • Latest comparable period on this page: Q2 2023.
  • Peer context will appear when enough companies report a comparable value for this metric.
  • Open the metric history first if you want to verify the exact period-to-period change.

Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.

Open Revenues YoY history Which companies report the highest revenue?

How to read key metrics on this page

These short guides explain what the headline metrics mean, what to compare next, and where to open the live SEC-backed example for this company.

Plain-English Guide

How to read Revenue on this page

Revenue is the sales a company reports from customers before most expenses are subtracted.

Why people care

People start here to understand business scale and whether demand is growing before they ask about margins or cash flow.

How to read it

Check the latest reported period first, then compare the same quarter or year against prior periods so seasonality does not distort the story.

Compare next

Compare revenue with gross profit, operating income, and operating cash flow to see whether sales are turning into healthy economics.

Revenue can jump because of acquisitions, pricing changes, or revenue-recognition rules, and reporting periods may differ across companies.

Open a live SEC-backed example

Open Revenue guide

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Key facts

  • Molekule Group, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q2 2023.
  • Headline metric: Operating Margin -147%.

Change

  • Operating Margin YoY change: -98%.
  • Most recent SEC facts end date: 09 Aug 2023.

Research use

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

View source filing

Latest SEC snapshot (2023-08-09) highlights Operating Margin -146.8%, Current Ratio 2.27x, and Quick Ratio 0.43x.

Compare This Company Through SEC-backed Metrics

Use these links to compare Molekule Group, Inc. against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

66.9/100

Balanced Confidence low

Financial Health

Current Ratio
2.27x
Quick Ratio
0.43x
Debt to Equity
1.12x

Strengths

Current Ratio and Revenues YoY

Watchpoints

Operating Margin

Key metrics snapshot

Profitability

Metric Latest value YoY change
Operating Margin -147% -98%

Financial Health

Metric Latest value YoY change
Current Ratio 2.27x -87%
Quick Ratio 0.43x -97%
Debt-to-equity 1.12x

Growth

Metric Latest value YoY change
Revenues YoY 18574%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 34,654,459 +125%
Common Stock, Shares, Outstanding 34,046,500 +121%
Common Stock, Value, Issued $340,465 +121%
Weighted Average Number of Shares Outstanding, Basic 33,017,565 +138%

Supporting Metrics

These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.

Metric Latest value YoY change
Accounts Payable, Current $6,568,044 +855%
Accounts Receivable, after Allowance for Credit Loss, Current $2,210,700 +7780%
Accrued Liabilities, Current $5,868,740 +439%
Additional Paid in Capital $83,184,034 +225%
Assets $125,440,012 +281%
Assets, Current $39,344,231 +28%
Cash and Cash Equivalents, at Carrying Value $5,269,376 -82%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,899,118 -80%
Common Stock, Par or Stated Value Per Share 0.01 0%
Common Stock, Shares Authorized 110,000,000 0%
Common Stock, Shares, Issued 34,046,500 +121%
Deferred Income Tax Liabilities, Net $1,504,526 +435%
Earnings Per Share, Basic -1 -21%
Earnings Per Share, Diluted -1 +7.5%
Goodwill $21,031,064
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $33,695,916 -191%
Interest Expense $1,443,009
Inventory, Net $29,432,880 +2830%
Liabilities $84,734,956 +407%
Liabilities and Equity $125,440,012 +281%
Liabilities, Current $17,296,455 +874%
Operating Income (Loss) $31,908,474 -152%
Operating Lease, Liability, Current $2,746,961
Operating Lease, Liability, Noncurrent $8,245,493
Operating Lease, Right-of-Use Asset $10,952,143
Other Assets, Noncurrent $184,854 +753%
Property, Plant and Equipment, Gross $9,499,734 +303%
Property, Plant and Equipment, Net $8,626,031 +291%
Research and Development Expense $2,262,633 -14%
Share-based Payment Arrangement, Expense $4,601,371 +79%
Stockholders' Equity Attributable to Parent $40,705,056 +151%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .